Amarin Corporation Plc Sponsored ADR(NASDAQ : AMRN)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| SHPG | Shire PLC Sponsored ADR | 0.24% | 178.58 | 0.4% | $137.09m | |
| PRGO | Perrigo Co. Plc | 0.48% | 73.34 | 6.8% | $93.10m | |
| JAZZ | Jazz Pharmaceuticals Plc | 0.68% | 163.03 | 2.2% | $71.22m | |
| MNK | Mallinckrodt Plc | -0.40% | 29.67 | 21.1% | $65.61m | |
| ENDP | Endo International Plc | 0.13% | 15.96 | 8.9% | $57.71m | |
| GWPH | GW Pharmaceuticals PLC Sponsored ADR | 2.98% | 153.64 | 6.8% | $51.91m | |
| PTLA | Portola Pharmaceuticals, Inc. | 1.31% | 28.63 | 7.7% | $39.01m | |
| UTHR | United Therapeutics Corporation | -0.27% | 125.86 | 14.4% | $38.69m | |
| SAGE | SAGE Therapeutics, Inc. | -1.45% | 144.83 | 9.6% | $36.37m | |
| CTLT | Catalent Inc | -0.33% | 42.74 | 2.4% | $36.15m | |
| ICPT | Intercept Pharmaceuticals, Inc. | -1.03% | 119.36 | 18.7% | $32.09m | |
| SUPN | Supernus Pharmaceuticals, Inc. | 2.13% | 47.90 | 6.2% | $28.67m | |
| PCRX | Pacira Pharmaceuticals, Inc. | 7.32% | 51.35 | 10.6% | $27.64m | |
| ZGNX | Zogenix, Inc. | -3.29% | 47.05 | 10.0% | $27.47m | |
| MDCO | Medicines Company | -0.18% | 33.60 | 21.8% | $24.49m |
Company Profile
Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It's product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. It has developed and markets Vascepa capsules through wholesale. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland.